A breast cancer diagnosis can be overwhelming, but there’s always reason for hope. New advancements in treatment are constantly being developed, offering more options and a brighter outlook for patients. One such advancement is Abemaciclib, a medication sold under the brand name Verzenio.
Understanding HR+, HER2- Breast Cancer:
If you’ve been diagnosed with breast cancer, your doctor will likely classify it based on specific characteristics. One important distinction is whether the cancer is hormone receptor-positive (HR+) or hormone receptor-negative (HR-). HR+ breast cancer cells are fueled by hormones like estrogen and progesterone. Another key factor is the presence of a protein called HER2. HER2-negative breast cancer does not have high levels of the HER2 protein. Abemaciclib is a targeted therapy specifically designed to treat HR+, HER2- breast cancer.
How Does Abemaciclib Work?
Cancer cells grow and multiply rapidly. Abemaciclib works by targeting a specific protein complex (CDK4/6) that plays a crucial role in this cell division process. By inhibiting this complex, Abemaciclib essentially slows down the growth and spread of HR+, HER2- breast cancer cells.
Potential Benefits of Abemaciclib:
Abemaciclib offers several potential benefits for individuals diagnosed with HR+, HER2- breast cancer:
Reduces the Risk of Recurrence: Studies have shown that Abemaciclib, when used in combination with other therapies, can significantly reduce the risk of breast cancer coming back after initial treatment.
Extends Time to Progression: For patients with metastatic (advanced) breast cancer, Abemaciclib can help delay the progression of the disease and extend the time before additional treatment is needed.
More Treatment Options: Abemaciclib offers a new avenue for treatment, providing additional options for individuals who may not have responded well to other therapies.
Treatment Considerations:
It’s important to understand that Abemaciclib is not a one-size-fits-all treatment. Your doctor will consider various factors, including your overall health, the stage of your cancer, and any other medications you’re taking, to determine if Abemaciclib is the right choice for you.
Here are some key things to discuss with your doctor:
Treatment Stage: Abemaciclib is approved for use in both early-stage and advanced-stage HR+, HER2- breast cancer. The specific treatment plan will vary depending on the stage of your cancer.
Combination Therapy: Abemaciclib is typically used in combination with other medications, such as hormone therapy or other targeted therapies.
Potential Side Effects: Like any medication, Abemaciclib can cause side effects. Some common side effects include diarrhea, fatigue, nausea, and decreased appetite. Your doctor will discuss potential side effects with you and how to manage them.
Before taking this medicine
Tell your doctor and pharmacist if you are allergic to abemaciclib, any other medications, or any of the ingredients in abemaciclib tablets.
To make sure abemaciclib is safe for you, tell your doctor if you have ever had:
•a fever, chills, or other signs of infection;
•lung or breathing problems;
•blood clots; or
•liver or kidney disease.
Abemaciclib may harm an unborn baby. You may need a pregnancy test to make sure you are not pregnant. Use effective birth control while using abemaciclib and for at least 3 weeks after your last dose. Tell your doctor right away if you become pregnant.
It may be harder for you to get a woman pregnant while you are using abemaciclib.
You should not breastfeed while using this medicine and for at least 3 weeks after your last dose.
Conclusion
A breast cancer diagnosis can be daunting, but advancements like Abemaciclib offer a glimmer of hope. This targeted therapy holds the potential to reduce recurrence risk and extend progression-free time, empowering patients with HR+, HER2- breast cancer to face the future with greater optimism. Remember, knowledge is key. Explore Abemaciclib with your doctor to see if it can become an ally in your fight against cancer.
Read Less